Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Nathan Ajiashvili

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
capital markets, Capital Markets, corporate
Office
New York
Active in the record
2020 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPODebt Capital MarketsM&APrivate Equity & BuyoutsVenture Capital & Growth
Sectors
Financial ServicesHealthcare & Life SciencesTechnology
Jurisdictions
GermanyIsraelNasdaqNew YorkUnited States

Recent deals

76 announced deals in the record
Latham Advises on Aspen Neuroscience’s US$140.6 Million IPO 3 Nov 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 141m Lead Capital Markets New York
Latham & Watkins Advises on Bambusa Therapeutics’ Upsized US$168.9 Million IPO 3 Nov 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 169m Lead Capital Markets New York
Latham Advises on Corxel Pharmaceuticals and Amanat Acquisition Corp.’s Business Combination Agreement to Create a Publicly Listed Obesity-Focused Biopharmaceutical Company 27 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP Lead corporate New York
Latham Advises on Pyxis Oncology’s Up to US$282.6 Million Public Offering 1 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 283m Lead Capital Markets New York
Latham Advises on Beta Bionics’ US$150 Million Public Offering of Common Stock and Pre-Funded Warrants 17 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m Lead Capital Markets New York
Latham Advises on Satellos’ US$50 Million ATM Offering 18 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 50m Lead Capital Markets
Latham Advises on MapLight Therapeutics’ US$150 Million Private Placement Financing 15 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m Lead corporate
Latham Represents Zentalis Pharmaceuticals in US$80.5 Million Underwritten Public Offering 15 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 80.5m Lead corporate
Latham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering 10 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 346m Lead Capital Markets New York
Latham & Watkins Represents AtaiBeckley in Sale to Lilly 17 Jul 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP Lead corporate
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Nathan Ajiashvili is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 76 deals for Nathan Ajiashvili

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction